ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Characterizing the Antitumor Effect of Coptis chinensis and Mume Fructus against Colorectal Cancer Based on Pharmacological Analysis

Gao, RuiJiao; Lv, Ying*南方医科大学; y
Evidence-based Complementary and Alternative Medicine2022-6-23DOI: 10.1155/2022/9061752
4被引14阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is the third most diagnosed cancer worldwide and is a significant cause of cancer-related deaths. Previous studies have observed that Coptis chinensis (CC) and Mume Fructus (MF) are effective against CRC, enteritis, and intestinal dysbiosis, but the chemical and pharmacological mechanisms remain poorly understood. In this study, we employed pharmacological network analysis to reveal mechanisms underlying the therapeutic effect of CC and MF against CRC. All compounds and targeted genes were obtained from the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP). Differentially expressed genes (DEGs) were identified based on GSE146587, GSE156720, and GSE184093 datasets. A protein-protein interaction (PPI) network was constructed to identify putative target genes of CC and MF. Ten key targeted genes were identified, including CCND1, ICAM1, IL1B, IL-6, MMP1, MMP3, MMP9, MYC, SERPINE1, and VEGFA. Among these genes, six (ICAM1, IL1B, IL-6, MMP1, MMP3, MMP9, and SERPINE1) were positively correlated with levels of effector memory CD4 T cells and natural killer T cells, and three (CCND1, MYC, and VEGFA) were negatively correlated with type 17 T helper cells and CD56dim natural killer cells. Molecular docking analysis showed that four compounds of CC and MF (kaempferol, oleanolic acid, quercetin, and ursolic acid) could affect CRC by interacting with target genes. Our study proved that pharmacological analysis could reliably assess the mechanism of traditional Chinese medicines for treating cancer.

学科与关键词

关键词
RHIZOMA
相关
加载中…
  • Anti-colon Cancer Effects of Dendrobium officinale Kimura & Migo Revealed by Network Pharmacology Integrated With Molecular Docking and Metabolomics Studies
    Tao, Shengchang; Li, Jinyan; Wang, Huan; Ding, Shaobo; Han, Weichao; He, Ruirong; Ren, Zhiyao; Wei, Gang*Frontiers in Medicine, 2022, 9: 879986.被引 4
  • Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis
    Yang, Yuanming; Hua, Yiwei; Chen, Weihuan; Zheng, Huan; Wu, Haomeng; Qin, Shumin*; Huang, Shaogang*Frontiers in Pharmacology, 2022, 13: 1037856.被引 4
  • Integrated network pharmacology and DSS-induced colitis model to determine the anti-colitis effect of Rheum palmatum L. and Coptis chinensis Franch in granules
    Wenxin Yan; Qian Feng; Yu Li; Yuefang Lin; Jingjing Yao; Zhen Jia; Linlin Lu*; Liang Liu*; Hua Zhou*Journal of Ethnopharmacology, 2023, 300: 115675.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2022-06-23
卷期
第 2022 卷
页码
9061752
DOI
10.1155/2022/9061752
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
general project of the Guangdong Bureau of Traditional Chinese Medicine [20213009]

作者

  • G

    Gao, RuiJiao (第一作者)

    southern med univ

  • L

    Lv, Ying (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417